PodParley PodParley
DTB Podcast

DTB Podcast

Bookmark

DTB Podcast is a health podcast hosted by BMJ Group. It has 188 episodes, with the latest published March 2026.

The Drug and Therapeutics Bulletin (DTB) Podcast is your source for practical, independent, and evidence-based information on drugs, medication, and prescribing. Join the Editor-in-Chief and Deputy Editor of DTB each month as they discuss the key highlights of the latest issue.DTB - dtb.bmj.com - is published by BMJ Group, and offers rigorous, independent evaluations and practical advice on treatments and disease management for doctors, pharmacists, and healthcare professionals. Subscribe to the DTB Podcast and get the latest drug and therapeutic insights.* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that pr

health ·en ·188 episodes

#
Title
1

Understanding clinical significance, and the new epinephrine nasal spray

2

GLP-1 drugs, reducing sedative use, and a thank you

3

Disinformation and misinformation, AI in primary care and antidepressant tapering

4

Prevention in primary care, elinzanetant for menopause, and a farewell to David.

5

Medicines - but at what cost, direct penicillin allergy challenge, and prescribing mistakes

6

Orphan drugs, allopurinol and CVD, mavacamten for obstructive hypertrophic cardiomyopathy

7

Antibiotic susceptibility reports, deprescribing, and heart failure drugs

8

AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease

9

National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis

10

Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD

11

The polypill revisited, cytisinicline for vaping cessation and a new co-host

12

Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD

13

Paying the price, liver problems with fezolinetant, systemic anticancer treatments

14

Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough

15

PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids

16

When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep

17

Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care

18

(Un)common sense in oncology, DOACs in device-detected AF, and hypertension in the elderly

19

Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl

20

Psychotropic medicines in children, warfarin vs DOAC in old age, and fezolinetant in menopause

21

Propranolol and its risk in overdose and managing COPD exacerbations

22

Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

23

Medicines and global warming, donanemab for AD, and cytisine for smoking cessation

24

Drug safety alerts, valproate safety (again) and a new contraceptive POP

25

Protecting consumers, tramadol-warfarin interaction and very low calorie diets

26

ADHD medicines shortages, fluoroquinolone safety, drugs not to prescribe

27

Continuity of care, statins and myasthenia gravis, and acne

28

Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity

29

BNF moving with the times; preventable deaths; plus an intro to pharmacogenetics

30

Taxing ill health, and what evidence for intravenous vitamins?

31

NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity

32

FeNO and asthma, low-dose aspirin and H pylori eradication, plus finerenone

33

July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage

34

DTB 60th anniversary podcast interview - Barbara Mintzes

35

Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant

36

May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics

37

When should you take antihypertensive medication. Prescribing for skin conditions in pregnancy

38

DTB 60th anniversary podcast interview - Joanna Girling

39

Penicillin allergy, lecanemab and Alzeimer’s disease, a new oral contraceptive and statins for all

40

Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy

41

DTB 60th anniversary podcast interview - John Dowden

42

Happy New Year, sad news from Australia, toxocarosis in humans and yet more on valproate safety

43

December 2022 - MHT and ’brain fog’, risks from sodium-containing paracetamol and 2022 revisited

44

DTB 60th anniversary podcast interview - Jo Congleton

45

November 2022 - FMT, methotrexate and COVID vaccine boosters, and Palforzia for peanut allergy

46

October 2022 - two freebies, advertising woes, paracetamol (again) and standing up to Pharma

47

September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin

48

August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid

49

July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin

50

June 2022 - a complaint, primary care spirometry, paracetamol and frailty, serotonin syndrome

URL copied to clipboard!